Ahead of an investor presentation in Frankfurt today, management has increased its guidance for FY26 following acquisitions/agreements to acquire three companies in the pharmaceutical sector and two in the optics and hearing segment.
Management is now guiding to gross merchandise volume of €1.7bn (€1.6bn previously), revenue of €1bn (€860m previously) and adjusted EBITDA of €70-80m, ie a margin of 7-8% (margin of 7.5-10% previously or adjusted EBITDA of €64.5-86m).
The new figures represent y-o-y growth from the current unchanged FY25 guidance for revenue of 36-40% and adjusted EBITDA of c 30-38%.
TMT | Comment
Industrials | Comment
Industrials | Comment